Relevance of barriers and facilitators in the use of health technology assessment in Colombia

Dams, Florian; Rodríguez, Javier Leonardo González; Cheung, Kei Long; Wijnen, Ben; Hiligsmann, Mickaël

doi:10.1080/13696998.2018.1449751

Cited by 6 publications

(5 citation statements)

References 16 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Of the 123 respondents who opened the questionnaire, 55 (45%) dropped out. This is comparable to previous studies, in which the drop-out rates were 72% 25 , 54% 26 , 42% 27 , and 30% 24 . Of those who dropped out, 19 completed the demographic section.…”

Section: Discussionsupporting

confidence: 90%

“…An initial list was identified via a scoping review completed for a comparable BWS study in the Netherlands 27 and verified for the Canadian setting. The same initial list was used as a point of departure for similar studies in Austria 24 , Colombia 25 and France, Germany, and the United Kingdom 26 . The list was translated into French by an independent translator in Canada and translation was verified by one of the study authors (MH).…”

Section: Identification Of Facilitators and Barriersmentioning

confidence: 99%

“…Fewer studies exist that identify the relative importance of influences on the use of evidence in health policymaking. To date, the relative importance of known barriers and facilitators to the use of HTA has been investigated in Austria 24 , Colombia 25 , Germany 26 , France 26 , the Netherlands 26,27 , and the United Kingdom 26 . A ranking of relative importance can serve to identify the order in which to address barriers and promote facilitators, with the assumption that any policy change is gradual and incremental.…”

Section: Introductionmentioning

confidence: 99%

See 2 more Smart Citations

The most important facilitators and barriers to the use of Health Technology Assessment in Canada: a best–worst scaling approach

Wranik

Székely

Mayer

et al. 2021

Journal of Medical Economics

Self Cite

View full text Add to dashboard Cite

Background: Health Technology Assessment (HTA), which can support public drug reimbursement decisions will play a core function in the planned national Pharmacare program in Canada. To address existing barriers to the use of HTA, these must be ranked in order of priority. The goal of this study was to access the relative importance of known facilitators and barriers to the use of HTA in the context of the Canadian health care system, with attention to differences between regions and stakeholder groups. Methods: We used the best-worst scaling object case approach to elicit a quantitative ranking of a list of 20 facilitators and 22 barriers. A sample of 68 Canadian HTA stakeholders, including members of expert committees, decision/policymakers, researchers/academics, and others participated in the study. Their task was to identify the most important and the least important item in 12 sub-sets of five facilitators and 14 sub-sets of five barriers. Findings: Relative Importance Scores derived via hierarchical Bayes analysis revealed relations, engagement, and contact between stakeholders as most important on both the barrier and facilitator sides. Other top-ranked facilitators included the availably of credible and relevant research. Other top-ranked barriers included inconsistencies in the evidence and limited generalizability. The availability of HTA guidelines did not rank highly on either side. The main limitation of the study was the challenge with reaching the relevant respondents; this was mitigated by involving the national HTA agency in the research. Conclusion: Canadian stakeholders consider the relationships within the HTA network among the most important. Policies should focus on strengthening these relationships. Future research should focus on the connectivity and distribution of knowledge and power within the HTA network.

show abstract

Section: Discussionsupporting

confidence: 90%

Section: Identification Of Facilitators and Barriersmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

The most important facilitators and barriers to the use of Health Technology Assessment in Canada: a best–worst scaling approach

Wranik

Székely

Mayer

et al. 2021

Journal of Medical Economics

Self Cite

View full text Add to dashboard Cite

show abstract

“…The cultural, social, legal, ethical, economic, technical, and medical criteria of an intervention in HTA should be examined, requiring special skills and competences [ 52 ]. In the curriculum of medical and pharmacy programs, there are some courses on the clinical aspect of technology, but other HTA skills have not been considered [ 53 ]. Developing and poor countries should work to minimize the costs of inappropriate decisions in the health sector; in doing so, one of their problems is allocating sufficient economic-financial resources to HTA.…”

Section: Discussionmentioning

confidence: 99%

A SWOT analysis of the development of health technology assessment in Iran

et al. 2023

View full text Add to dashboard Cite

Background Health systems need to prioritize their services, ensuring efficiency and equitable health provision allocation and access. Alongside, health technology assessment (HTA) seeks to systematically evaluate various aspects of health technologies to be used by policy- and decision-makers. In the present study, we aim to identify strengths, weaknesses, opportunities, and threats in developing an HTA in Iran. Method This qualitative study was conducted using 45 semi-structured interviews from September 2020 to March 2021. Participants were selected from key individuals involved in health and other health-related sectors. Based on the objectives of the study, we used purposive sampling (snowball sampling) to select individuals. The range of length of the interviews was between 45 to 75 minutes. Four authors of the present study carefully reviewed the transcripts of interviews. Meanwhile, the data were coded on the four domains of strengths, weaknesses, opportunities, and threats (SWOT). Transcribed interviews were then entered into the software and analyzed. Data management was performed using MAXQDA software, and also analyzed using directed content analysis. Results Participants identified eleven strengths for HTA in Iran, namely the establishment of an administrative unit for HTA within the Ministry of Health and Medical Education (MOHME); university-level courses and degrees for HTA; adapted approach of HTA models to the Iranian context; HTA is mentioned as a priority on the agenda in upstream documents and government strategic plans. On the other hand, sixteen weaknesses in developing HTA in Iran were identified: unavailability of a well-defined organizational position for using HTA graduates; HTA advantages and its basic concept are unfamiliar to many managers and decision-makers; weak inter-sectoral collaboration in HTA-related research and key stakeholders; and, failure to use HTA in primary health care. Also, participants identified opportunities for HTA development in Iran: support from the political side for reducing national health expenditures; commitment and planning to achieve universal health coverage (on behalf of the government and parliament); improved communication among all stakeholders engaged in the health system; decentralization and regionalization of decisions; and capacity building to use HTA in organizations outside the MOHME. High inflation and bad economic situation; poor transparency in decisions; lack of support from insurance companies; lack of sufficient data to conduct HTA research; rapid change of managers in the health system; and economic sanctions against Iran are threats to the developmental path of HTA in Iran. Conclusion HTA can be properly developed in Iran if we use its strengths and opportunities, and address its weaknesses and threats.

show abstract

“…For most low and middle-income countries, capacity building related to HTA is a major challenge, which hinders HTA on many levels [35,38,47]. For instance, it has been previously reported that a shortage of qualified personnel in Brazil compromises the methodological quality of HTA reports, resulting in a low number of reports finished in time [48].…”

Section: Discussionmentioning

confidence: 99%

Expectations for the Development of Health Technology Assessment in Brazil

Galendi

Caramori

Lemmen

et al. 2021

IJERPH

View full text Add to dashboard Cite

The implementation of health technology assessment (HTA) in emerging countries depends on the characteristics of the health care system and the needs of public health care. The objective of this survey was to investigate experts’ expectations for the development of HTA in Brazil and to derive measures to strengthen the impact of HTA in Brazil on health care decisions. Based on a scoping literature review, a questionnaire was developed proposing eight theses for seven domains of HTA: (i) capacity building, (ii) public involvement, (iii) role of cost-effectiveness analysis (CEA), (iv) institutional framework, (v) scope of HTA studies, (vi) methodology of HTA, and (vii) HTA as the basis for jurisdiction. Thirty experts responded in full to the survey and agreed to five of the eight theses proposed. Experts suggested several measures to promote HTA within the scope of each domain, thus addressing capacity building related to HTA, availability, and reliability of population data, and legal endowment of the HTA system. Finally, HTA processes in Brazil should also address public health issues (e.g., appraisal of interventions directed at chronic diseases).

show abstract

Relevance of barriers and facilitators in the use of health technology assessment in Colombia

Abstract: The study suggests that barriers and facilitators related to technical aspects of processing HTA reports and to the contact and interaction between researchers and policymakers had the greatest importance in Colombia.

Cited by 6 publications

References 16 publications

The most important facilitators and barriers to the use of Health Technology Assessment in Canada: a best–worst scaling approach

The most important facilitators and barriers to the use of Health Technology Assessment in Canada: a best–worst scaling approach

A SWOT analysis of the development of health technology assessment in Iran

Expectations for the Development of Health Technology Assessment in Brazil

Contact Info

Product

Resources

About